Protagonist Therapeutics Inc (PTGX)
$41.08 $0.46 (1.14%) 11:09 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.45B -
Day's Range
$39.60 - $41.35 -
Volume
647,707 -
52 Week Low / High
$20.36 - $48.89 -
PE Ratio
14.99x -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 5
- Strong Buy
- 4
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $40.75
- Target Price
Company News
-
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines — Sep 10th, 2024
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines Truist Securities initiated coverage on Protagonist Therapeutics Inc (NASDAQ:PTGX), citing its first-in-class lead asset with encouraging Phase 2 data in a rare form of blood cancer an...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
-
Protagonist Therapeutics Inc. (PTGX): Advancing Treatments for Autoimmune Diseases — Oct 18th, 2024
We recently published a list of 8 High Growth High Margin Stocks to Invest In Now. In this article, we are going to take a look at where Protagonist Therapeutics Inc. (NASDAQ:PTGX) stands against other high growth high market stocks to invest in. How Market Trends Shape Opportunities Whe...
Portfolio
Comprised of 1 portfolios